User Ratings

Your rating: None (1 vote)
Your rating: None
Your rating: None
Add your comments

Isolation of Amniotic Mesenchymal Stem Cells

Fabio Marongiu1,  Roberto Gramignoli1,  Qian Sun1,  Veysel Tahan1,  Toshio Miki1,  Kenneth Dorko1,  Ewa Ellis1,  Stephen C. Strom1

1University of Pittsburgh, Pittsburgh, Pennsylvania

Unit Number: 
Unit 1E.5
DOI: 
10.1002/9780470151808.sc01e05s12
Online Posting Date: 
March, 2010
GO TO THE FULL TEXT:
PDF or HTML at Wiley Online Library
Are you the author of this protocol? Login or register and return to this page.
Learn more about the author(s): 
Fabio Marongiu

Abstract

Mesenchymal stem cells (MSCs) have the ability to differentiate into osteocytes, chondrocytes, and adipocytes and possess immunomodulatory properties. Amniotic membrane from human term placenta is a potential source of multipotent MSCs that could be useful for regenerative medicine. This unit describes a detailed and simple protocol for the isolation of amniotic mesenchymal cells. We also introduce a simple density separation technique for the purification of this cell type from possible contamination with amniotic epithelial cells. Curr. Protoc. Stem Cell Biol. 12:1E.5.1-1E.5.11. © 2010 by John Wiley & Sons, Inc.

Keywords: placenta; amnion; mesenchymal stem cells; MSC

     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Table of Contents

  • Introduction
  • Basic Protocol: Isolation of Human Amniotic Mesenchymal Stem Cells
  • Alternate Protocol: Purification of Amniotic Mesenchymal Cells from Amniotic Epithelial Cells
  • Reagents and Solutions
  • Commentary
  • Literature Cited
  • Figures
  • Tables
     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Materials

Basic Protocol: Isolation of Human Amniotic Mesenchymal Stem Cells

 Materials
  • Hanks' balanced salt solution (HBSS, calcium- and magnesium-free; Lonza, cat. no. 04-315Q)
  • 70% (w/v) ethanol
  • 0.05% (w/v) trypsin/EDTA (Invitrogen, cat. no. 25300-054)
  • Term placenta, freshly delivered
  • Digestion Solution (see recipe)
  • Standard culture medium (see recipe)
  • Laminar flow cabinet equipped with the following:
    • Absorbent bench paper
    • Sterile field 16 × 29–in.
    • Sterile scalpel
    • 500-ml beakers (2)
    • Sterile Scissors (2) and forceps (2)
    • Sterile gloves and sleeves
    • 100-µm nylon cell strainers (4)
    • 50-ml Falcon centrifuge tubes (8)
    • Centrifuge
    • 37°C incubator
    • 37°C water bath
  • Additional reagents and equipment for cell counting (unit 1C.3)

Alternate Protocol: Purification of Amniotic Mesenchymal Cells from Amniotic Epithelial Cells

 Additional Materials (also see Basic Protocol)
  • Isolated amniotic mesenchymal cells in culture (see the Basic Protocol)
  • 0.25% (w/v) trypsin/EDTA (Invitrogen, cat. no. 25200-056)
  • Percoll (Sigma, cat. no. P4937)
  • 10× HBSS (Invitrogen, cat. no. 14065-056)
  • Hanks' balanced salt solution, calcium- and magnesium-free (HBSS-CMF; Lonza, cat. no. 04-3150)
  • 15-ml conical tubes
     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Figures

  • Figure 1E.5.1
    Cross-section of human amnion.

  • Figure 1E.5.2
    Sterile equipment for the isolation of hAECs.

  • Figure 1E.5.3
    Placenta with amnion membrane facing up.

  • Figure 1E.5.4
    Placenta with an X-shaped incision.

  • Figure 1E.5.5
    Peeling the amnion membrane.

  • Figure 1E.5.6
    Washing the amniotic membrane in HBSS.

  • Figure 1E.5.7
    Schematic representation of density separation with Percoll gradients before (A) and after (B) centrifugation.

  • Figure 1E.5.8
    Morphology of hAMSCs and hAECs cultured for 24 hr after Percoll density separation. (A) Fraction 1: hAMSC monolayer; (B) fraction 2: islands of hAECs (red arrows) on a hAMSC monolayer; (C) fraction 3: islands of hAMSCs (yellow arrows) on a hAEC monolayer; (D) fraction 4: hAEC monolayer.

  • Figure 1E.5.9
    FACS analysis of MSC marker expression on hAMSCs immediately after isolation. The percentage of the positive fraction is relative to isotype controls.

Literature Cited

Literature Cited
    Kobayashi, M., Yakuwa, T., Sasaki, K., Sato, K., Kikuchi, K., Kamo, I., Yokoyama, Y., and Sakuragawa, N. 2008. Multilineage potential of side population cells from human amnion mesenchymal layer. Cell Transplant. 17:291-301.
    Magatti, M., De Murani, S., Vertua, E., Gibelli, L., Wengler, G.S., and Parolini, O. 2008. Human amnion mesenchyme harbors cells with allogeneic T-cell suppression and stimulation capabilities. Stem Cells 26:182-192.
    Miki, T. and Strom, S.C. 2006. Amnion-derived pluripotent/multipotent stem cells. Stem Cell Rev. 2:133-142.
    Miki, T., Lehmann, T., Cai, H., Stotz, D.B., and Strom, S.C. 2005. Stem cell characteristics of amniotic epithelial cells. Stem Cells 23:1549-1559.
    Parolini, O., Alviano, F., Bagnara, G.P., Bilic, G., Bühring, H.J., Evangelista, M., Hennerbichier, S., Liu, B., Magatti, M., Mao, N., Miki, T., Marongiu, F., Nakajima, H., Nikaido, T., Portmann-Lanz, C.B., Sankar, V., Soncini, M., Stadler, G., Surbek, D., Takahashi, T.A., Redi, H., Sakuragawa, N., Wolbank, S., Zeisberger, S., Zisch, A., and Strom, S.C. 2008. Concise review: Isolation and characterization of cells from human term placenta: Outcome of the first International Workshop on Placenta Derived Stem Cells. Stem Cells 26:300-311.
    Soncini, M., Vertua, E., Gibelli, L., Zorzi, F., Denegri, M., Albertini, A., Wengler, G.S., and Parolini, O. 2007. Isolation and characterization of mesenchymal cells from human fetal membranes. J. Tissue Eng. Regen. Med. 1:296-305.
    Wei, J.P., Nawata, M., Wakitani, S., Kametani, K., Ota, M., Toda, A., Konishi, I., Ebara, S., and Nikaido, T. 2009. Human amniotic mesenchymal cells differentiate into chondrocytes. Cloning Stem Cells 11:19-26.
     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library
Looking for Answers?
Do you have tips, tricks, or improvements to share?

Join the Conversation

Post new comment

The content of this field is kept private and will not be shown publicly.
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.